tiprankstipranks
Advertisement
Advertisement

LXEO Stock Latest News

Citizens biotech analysts hold an analyst/industry conference call
The FlyCitizens biotech analysts hold an analyst/industry conference call
10d ago
BIIB
DSGN
Lexeo Shareholders Reelect Directors, Ratify KPMG Auditor
PremiumCompany Announcements
Lexeo Shareholders Reelect Directors, Ratify KPMG Auditor
13d ago
8K
LXEO
Lexeo Therapeutics price target lowered to $9 from $12 at JPMorgan
PremiumThe Fly
Lexeo Therapeutics price target lowered to $9 from $12 at JPMorgan
17d ago
LXEO
Lexeo finalizes SUNRISE-FA 2 pivotal trial protocol, statistical analysis plan
PremiumThe Fly
Lexeo finalizes SUNRISE-FA 2 pivotal trial protocol, statistical analysis plan
27d ago
LXEO
Lexeo Advances Pivotal LX2006 Trial for FA Cardiomyopathy
PremiumCompany Announcements
Lexeo Advances Pivotal LX2006 Trial for FA Cardiomyopathy
27d ago
8K
LXEO
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe FlyActing FDA head vows to block political interference, Endpoint News says
1M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
1M ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
Premium
The Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
2M ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe Fly
Trump Trade: U.S. plans AI security order without required model tests
2M ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
2M ago
DYN
RNA
Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c)
PremiumThe Fly
Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c)
2M ago
LXEO
Lexeo Highlights Q1 Progress Advancing Cardiac Gene Therapies
PremiumCompany Announcements
Lexeo Highlights Q1 Progress Advancing Cardiac Gene Therapies
2M ago
8K
LXEO
Lexeo Therapeutics Adds Genomic Medicine Leader to Board
PremiumCompany AnnouncementsLexeo Therapeutics Adds Genomic Medicine Leader to Board
2M ago
8K
LXEO
Lexeo Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Lexeo Therapeutics management to meet with Cantor Fitzgerald
3M ago
LXEO
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
3M ago
DYN
RNA
Lexeo Therapeutics Advances Cardiac Gene Therapies, Strengthens Finances
PremiumCompany Announcements
Lexeo Therapeutics Advances Cardiac Gene Therapies, Strengthens Finances
3M ago
8K
LXEO
Lexeo Therapeutics reports Q4 EPS (27c), consensus (30c)
PremiumThe Fly
Lexeo Therapeutics reports Q4 EPS (27c), consensus (30c)
3M ago
LXEO
LXEO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LXEO Upcoming Earnings Report: What to Expect?
4M ago
LXEO
Controversial Prasad leaving FDA, NYT reports
PremiumThe Fly
Controversial Prasad leaving FDA, NYT reports
4M ago
AZN
BMY
Lexeo Therapeutics Announces Head of Research Transition
PremiumCompany AnnouncementsLexeo Therapeutics Announces Head of Research Transition
5M ago
8K
LXEO
Lexeo Therapeutics Announces Key Executive Leadership Changes
Premium
Company Announcements
Lexeo Therapeutics Announces Key Executive Leadership Changes
6M ago
8K
LXEO
Lexeo appoints Narinder Bhalla as CMO, Eric Adler as CEO, Myoventive
Premium
The Fly
Lexeo appoints Narinder Bhalla as CMO, Eric Adler as CEO, Myoventive
6M ago
LXEO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >